IP Library Granted Patent US 10,668,220
Granted Patent B2
US 10,668,220 · App. 15/544,083 · Granted Jun 2, 2020

Medicament delivery device with usage monitoring

Inventors: Nikolaj Hautaviita (Bro, SE); Rasmus Renstad (Stockholm, SE); Daniel Säll (Segeltorp, SE); Stefan Gylleby (Stockholm, SE); Per Lindstedt (Värmdö, SE)
Assignee: SHL MEDICAL AG
A61M5/31501A61J2200/30A61J2205/60A61M2005/2013A61M2005/2073A61M2205/13A61M2205/276A61M2205/332A61M2205/3375A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,668,220
App. No.
15/544,083
Granted
Jun 2, 2020
Kind
B2
Abstract

A medicament delivery device is presented having a housing that is arranged to accommodate a medicament container, a drive unit operably arranged to act on the medicament container upon activation, an activation mechanism operably arranged to be operated by a user, an activation preventing mechanism operably arranged to prevent the activation mechanism to be activated, an usage management module arranged to be operated by a user, which usage management module is designed as an attachable unit to the medicament delivery device. First keying elements are arranged on the device and on the usage management module designed to interact with each other when attaching said usage management module, such as to cause a deactivation of the activation preventing mechanism to allow operation of the activation mechanism. The usage management module can include a monitoring circuit arranged to monitor the use of the medicament delivery device.

Claims (20)

1. A medicament delivery device comprising

a housing constructed to accommodate a medicament container;

a drive unit configured to operably act on the medicament container upon activation;

an activation mechanism configured for operation by a user;

an activation preventing mechanism operably configured that prevents the user from activating the activation mechanism;

a usage management module configured for operation by a user, where the usage management module is attachable to the housing; and

first keying elements arranged both within the housing and on the usage management module that interact with each other when the usage management module is attached to the housing, where the attachment causes rotation of the activation preventing mechanism that then allows operation of the activation mechanism, where the usage management module comprises a monitoring circuit that monitors the use of the medicament delivery device.

2. The medicament delivery device according to claim 1 , wherein said monitoring circuit is activated upon attachment of said usage management module to said medicament delivery device.

3. The medicament delivery device according to claim 1 , wherein said monitoring circuit is activated upon a change of usage status of said medicament delivery device.

4. The medicament delivery device according to claim 1 , wherein said monitoring circuit is arranged with sensor elements capable of monitoring and registering current status and status changes of said medicament delivery device upon use of the medicament delivery device.

5. The medicament delivery device according to claim 1 , wherein said monitoring circuit comprises storage elements capable of storing registered data derived during the monitoring and registering.

6. The medicament delivery device according to claim 1 , wherein said usage management module comprises at least one communication circuit designed and arranged to communicate with external communication elements.

7. The medicament delivery device according to claim 2 , wherein said monitoring circuit is activated upon an end of a dose delivery operation.

8. The medicament delivery device according to claim 6 , wherein said communication circuits comprise near range communication technology.

9. The medicament delivery device according to claim 6 , wherein said communication circuits comprise wireless local area network communication technology.

10. The medicament delivery device according to claim 6 , wherein said communication circuits are operable to transmit registered data derived during the monitoring and registering to external storage sources.

11. The medicament delivery device according to claim 6 , wherein the at least one communication circuit is operable to receive data pertaining to the usage of the medicament delivery device, wherein said usage management module further comprises a communication circuit operable to communicate with a user of the medicament delivery device.

12. The medicament delivery device according to claim 6 , wherein said usage management module further comprises a global positioning circuit, capable of obtaining information regarding an actual position of the activated medicament delivery device and wherein the at least one communication circuit is designed to transmit position information to external sources.

13. The medicament delivery device according to claim 6 , wherein the at least one communication circuit is arranged to communicate with communication elements arranged in the medicament delivery device.

14. The medicament delivery device according to claim 9 , wherein said communication circuits comprise digital cellular network communication technology.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2018
From: CAREBAY EUROPE LIMITED
To: SHL MEDICAL AG
Reel/Frame 047586/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2017
From: HAUTAVIITA, NIKOLAJ; RENSTAD, RASMUS; SALL, DANIEL; GYLLEBY, STEFAN; LINDSTEDT, PER
To: CAREBAY EUROPE LTD
Reel/Frame 043446/0962 →
Priority Claims (1)
SE 1550144 · Feb 9, 2015 · national
Continuity (1)
Related Publication 20180008779A1 · Jan 11, 2018
Cited By (2)
US 12,274,867 US 12,397,118